PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 20101735-5 2010 RESULTS: We report here that pharmacological inhibition of the MEK/ERK pathway by AZD6244 enhanced the antitumor and antiangiogenic activities of mTOR inhibitor RAPA in both orthotopic and ectopic models of HCC. AZD 6244 82-89 mechanistic target of rapamycin kinase Homo sapiens 146-150